ARTIVION, INC. (AORT) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Win; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Win; EPS growth Win.
59/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 7 wins, 5 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
LoseAORT / S&P -38.64% / 15.20% |
WinAORT / S&P 16.40% / 15.00% |
LoseAORT / S&P -83.33% / 50.40% |
| 2026-Q11/3 |
LoseAORT / S&P -19.71% / -4.33% |
WinAORT / S&P 17.59% / 11.30% |
LoseAORT / S&P -148.00% / 27.70% |
| 2025-Q42/3 |
WinAORT / S&P 7.72% / 2.65% |
WinAORT / S&P 13.59% / 9.00% |
LoseAORT / S&P -164.52% / 13.40% |
| 2025-Q33/3 |
WinAORT / S&P 36.14% / 8.12% |
WinAORT / S&P 9.81% / 4.61% |
WinAORT / S&P 1100.00% / 13.45% |
| 2025-Q23/3 |
WinAORT / S&P 26.53% / 10.94% |
WinAORT / S&P 7.44% / 4.83% |
WinAORT / S&P 100.00% / 10.63% |
| 2025-Q12/3 |
LoseAORT / S&P -14.03% / -4.27% |
WinAORT / S&P 5.94% / 4.98% |
WinAORT / S&P 108.33% / 10.57% |
| 2024-Q42/3 |
WinAORT / S&P 7.40% / 2.41% |
WinAORT / S&P 9.75% / 5.25% |
LoseAORT / S&P -58.67% / 6.15% |
| 2024-Q31/3 |
LoseAORT / S&P 3.78% / 5.89% |
WinAORT / S&P 13.29% / 5.89% |
LoseAORT / S&P -96.67% / 6.11% |
| 2024-Q22/3 |
WinAORT / S&P 21.22% / 4.28% |
WinAORT / S&P 14.68% / 5.38% |
LoseAORT / S&P -70.00% / 5.12% |
| 2024-Q12/3 |
WinAORT / S&P 18.34% / 10.56% |
WinAORT / S&P 15.13% / 5.71% |
LoseAORT / S&P -67.12% / 5.59% |
| 2023-Q43/3 |
WinAORT / S&P 17.94% / 11.69% |
WinAORT / S&P 12.82% / 6.81% |
WinAORT / S&P 56.25% / 7.78% |
| 2023-Q31/3 |
LoseAORT / S&P -11.81% / -3.27% |
WinAORT / S&P 8.27% / 7.52% |
LoseAORT / S&P -42.31% / -5.03% |
| 2023-Q22/3 |
WinAORT / S&P 31.22% / 8.74% |
LoseAORT / S&P 6.33% / 9.50% |
WinAORT / S&P 59.09% / -8.57% |
| 2023-Q12/3 |
WinAORT / S&P 8.09% / 7.50% |
LoseAORT / S&P 4.87% / 10.77% |
WinAORT / S&P 87.18% / -15.69% |
| 2022-Q41/3 |
LoseAORT / S&P -12.43% / 7.56% |
LoseAORT / S&P 5.00% / 11.88% |
WinAORT / S&P 23.08% / -17.99% |
| 2022-Q30/3 |
LoseAORT / S&P -26.69% / -4.88% |
LoseAORT / S&P 9.20% / 13.47% |
LoseAORT / S&P -3566.67% / -1.41% |
| 2022-Q22/3 |
WinAORT / S&P -11.69% / -16.10% |
LoseAORT / S&P 10.31% / 13.71% |
WinAORT / S&P 41.94% / 11.04% |
| 2022-Q12/3 |
WinAORT / S&P 5.06% / -4.60% |
WinAORT / S&P 18.26% / 15.97% |
LoseAORT / S&P 11.43% / 42.23% |
| 2021-Q41/3 |
LoseAORT / S&P -8.70% / 11.03% |
WinAORT / S&P 18.01% / 15.00% |
LoseAORT / S&P -13.33% / 96.40% |
| 2021-Q31/3 |
LoseAORT / S&P -21.51% / 0.58% |
WinAORT / S&P 12.67% / 10.77% |
LoseAORT / S&P -108.11% / 69.42% |
| 2021-Q22/3 |
WinAORT / S&P 25.78% / 8.55% |
WinAORT / S&P 8.72% / 6.58% |
LoseAORT / S&P 6.90% / 51.81% |
| 2021-Q11/3 |
LoseAORT / S&P -4.36% / 6.17% |
LoseAORT / S&P -6.27% / -1.06% |
WinAORT / S&P 191.67% / 7.39% |
| 2020-Q41/3 |
WinAORT / S&P 27.83% / 12.15% |
LoseAORT / S&P -8.32% / -3.72% |
LoseAORT / S&P -1000.00% / -33.42% |
| 2020-Q30/3 |
LoseAORT / S&P -3.65% / 8.93% |
LoseAORT / S&P -7.03% / -2.04% |
LoseAORT / S&P -1025.00% / -27.10% |
| 2020-Q20/3 |
LoseAORT / S&P 13.30% / 20.54% |
LoseAORT / S&P -4.89% / -0.46% |
LoseAORT / S&P -462.50% / -27.11% |
| 2020-Q10/3 |
LoseAORT / S&P -37.54% / -19.60% |
LoseAORT / S&P 2.51% / 3.47% |
LoseAORT / S&P -700.00% / -14.75% |
| 2019-Q40/3 |
LoseAORT / S&P -0.22% / 9.07% |
LoseAORT / S&P 5.09% / 5.36% |
LoseAORT / S&P -162.50% / 2.99% |
| 2019-Q31/3 |
LoseAORT / S&P -9.29% / 1.70% |
WinAORT / S&P 10.67% / 5.02% |
LoseAORT / S&P -128.57% / 0.21% |
| 2019-Q21/3 |
LoseAORT / S&P 2.61% / 4.30% |
WinAORT / S&P 19.26% / 6.64% |
LoseAORT / S&P -157.14% / 8.65% |
| 2019-Q11/3 |
LoseAORT / S&P 2.78% / 13.65% |
WinAORT / S&P 29.92% / 8.12% |
LoseAORT / S&P -133.33% / 14.29% |
| 2018-Q41/3 |
LoseAORT / S&P -19.38% / -13.52% |
WinAORT / S&P 38.55% / 9.05% |
LoseAORT / S&P -172.73% / 18.23% |
| 2018-Q32/3 |
WinAORT / S&P 26.39% / 7.71% |
WinAORT / S&P 36.26% / 10.21% |
LoseAORT / S&P -151.85% / 19.06% |
| 2018-Q22/3 |
WinAORT / S&P 38.90% / 3.43% |
WinAORT / S&P 24.08% / 9.03% |
LoseAORT / S&P -143.75% / 14.46% |
| 2018-Q12/3 |
WinAORT / S&P 4.70% / -0.76% |
WinAORT / S&P 13.25% / 7.68% |
LoseAORT / S&P -120.00% / 12.46% |
| 2017-Q40/3 |
LoseAORT / S&P -15.64% / 6.64% |
LoseAORT / S&P 5.17% / 7.03% |
LoseAORT / S&P -65.63% / 13.82% |
| 2017-Q31/3 |
WinAORT / S&P 13.78% / 4.48% |
LoseAORT / S&P 3.83% / 5.68% |
LoseAORT / S&P -18.18% / 17.57% |
| 2017-Q22/3 |
WinAORT / S&P 19.82% / 3.09% |
WinAORT / S&P 9.91% / 4.83% |
LoseAORT / S&P 3.23% / 17.74% |
| 2017-Q12/3 |
LoseAORT / S&P -13.05% / 6.07% |
WinAORT / S&P 17.63% / 3.67% |
WinAORT / S&P 36.36% / 13.32% |
| 2016-Q43/3 |
WinAORT / S&P 8.99% / 3.82% |
WinAORT / S&P 23.63% / 2.09% |
WinAORT / S&P 146.15% / 7.05% |
| 2016-Q33/3 |
WinAORT / S&P 48.77% / 3.85% |
WinAORT / S&P 22.33% / 0.20% |
WinAORT / S&P 230.00% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | AORT total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -39.29% | 20.78% |
| Annualized return | -39.29% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | AORT total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 0.98% | 83.14% |
| Annualized return | 0.20% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | AORT total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 68.37% | 319.30% |
| Annualized return | 5.35% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |